DETERMINE Trial Treatment Arm 3: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers.

Conditions:   Solid Tumor;   Haematological Malignancy;   Malignancy;   Malignant Neoplasm;   Lymphoproliferative Disorders;   Neoplasms by Histologic Type;   Neoplasms by Site;   Cancer;   Brain Neoplasms;   Melanoma;   Glioma Intervention:   Drug: Entrectinib Sponsors:   Cancer Research UK;   University of Manchester;   University of Birmingham;   Royal Marsden NHS Foundation Trust;   Hoffmann-La Roche Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials